From Target Focused to High Content Screening in Nutraceutical Discovery
Ann Fowler, Senior Scientist, DSM Nutritional Products, speaking at Screening Europe
Primary, iPS and Stem Cells: Emerging Tools for HTS?
Richard Elgen, President, Bio-discovery, PerkinElmer, speaking at Screening Europe 2010
High-throughput Screening in Human Embryonic Stem Cells for Drug Discovery
Sabrina C. Desbordes, Senior Postdoctoral Fellow, PRBB-Center for Genomic Regulation (CRG), speaking at Screening Europe 2010
Development of an AlphaScreen Assay for Epigenetic Peptide-Protein Interactions: A Target-Family Approach to the Discovery of MBT Antagonists
Tim Wigle, Researcher, University of North Carolina, speaking at Probe Discovery 2009
T-Cell Monitoring of Clinical Samples – Precise and Robust Assays based on DNA Methylation Markers
Ulrich Hoffmueller, Chief Business Officer, Epiontis GmbH, speaking at European Biomarkers Summit 2009
Experiences in Fragment-Based Lead Discovery
Ben Davis, Principal Scientist, NMR, Vernalis, speaking at Screening Europe 2010
Excitement Over Automated Electrophysiology: Heat Activation of TRPV1 and Action Potentials of Stem Cell Derived Cardiomyocytes
Rodolfo Haedo, Nanion Technologies, General Manager, speaking at Ion Channel Targets 2010.
Quartz and Glass Nanopore Membranes for Ultra-low Noise Measurement of Ion Channel Activity
Prithwish Pal, Electronic Biosciences, Research Scientist, speaking at Ion Channel Targets 2010.
Developing Novel Chloride-Channel Inhibitors
Merritt Maduke, Stanford School of Medicine, Associate Professor, speaking at Ion Channel Targets 2010.